The datademonstrated that Ad-TRAIL and Ad-TRAIL-MRE-1-133-218 had a similargrowth-inhibiting effect on both T24 and RT-4 bladder cancers (Figure 4a and b). This evidence concerns the gene TNFSF10 and urinary bladder carcinoma.